HomeBUSINESS
BUSINESS

JCR Side Asked GSK to Revise Capital Alliance: CEO Ashida
(Nov.6.2017)

JCR CEO Shin Ashida
It was JCR Pharmaceuticals that proposed a reduction in GlaxoSmithKline plc’s stake in the company, which led to the dissolution of their capital alliance in September, with the Japanese firm newly forming a tie-up with major wholesaler Medipal Holdings, according to JCR CEO Shin Ashida ...
(LOG IN FOR FULL STORY)

News Calendar